RFK Jr. sets his sights on linking antidepressants to mass violence

The health secretary’s crusade to Make America Healthy Again has vital mental health medications on the agenda

Robert F. Kennedy Jr. speaks during a discussion at The Official MAHA Summit
Experts have disputed Kennedy’s assertions about psychiatric medication and mass violence
(Image credit: Alex Wong / Staff / Getty Images)

In line with his rhetoric claiming there could be a link between vaccines and other medications and autism, Secretary of Health and Human Services Robert F. Kennedy Jr. has turned his attention to another class of drugs he believes could be linked to acts of mass violence. Kennedy has recently reiterated his intention to study antidepressant medications, such as selective serotonin reuptake inhibitors, or SSRIs.

Why is Kennedy scrutinizing antidepressants?

Health officials have “long monitored the side effects of such drugs, which millions of people use,” said Politifact. While new research could supply fresh findings, “existing data points don’t reflect that SSRIs cause mass violence.”

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

The idea that psychiatric medications can “set off mass shooters certainly isn’t new,” said Gizmodo. While Kennedy has claimed “scientists are afraid to study the topic,” several studies have “tried to look for a possible association between the use of these drugs and mass violence.” While none of the existing data support a causative link between the drugs and violence, suicidal ideation does appear to be a “substantial mental health factor.” That could explain why some research has found a potential link between antidepressant use and violence in general, said Ragy Girgis, a professor of clinical psychiatry at Columbia University’s Vagelos College of Physicians and Surgeons, to Gizmodo. They find a close relationship because “people who are suicidal or violent also have much worse depression.” People with worse depression are “more likely to be treated with antidepressant medications,” Girgis said. “But it’s not causative.”

What do experts think of RFK Jr.’s claims?

SSRIs are “generally safe and effective medications,” and there is “no overwhelming evidence that these drugs alone would cause patients who are taking them to commit acts of violence,” said Gregory Scott Brown, the chair of the American Psychiatric Association’s Council on Communications, to Gizmodo. The California State Association of Psychiatrists issued a rebuttal of RFK Jr.’s attempt to link SSRIs to mass shootings during his remarks in September. “This is simply not true,” the CSAP said in a statement. What is most worrying is that “such statements can scare people away from getting the care they need and deserve.”

Sensationalism may lead people to try to blame SSRIs for mass shootings, Girgis said to Gizmodo. Reports of shooters taking psychiatric medication “tend to make the event more of a headline and more attention-grabbing.” That is “one reason there’s this attention bias to it.”

Equating SSRI users with violence risks unnecessarily stigmatizing mental health conditions, said Keith Humphreys, a professor of psychiatry and behavioral sciences at Stanford University, to Axios. There are “depressed people, people with schizophrenia, anxious people in every other country,” but they can not “get guns as easily as you can get them here,” he added. It is a “distraction from the real issue.”

Theara Coleman, The Week US

Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.